Multiple hamartoma syndrome
Multiple hamartoma syndrome, also known as Cowden syndrome, is a rare genetic disorder characterized by the development of multiple noncancerous, tumor-like growths called hamartomas in various parts of the body. This condition is associated with an increased risk of developing certain types of cancer, particularly breast cancer, thyroid cancer, and endometrial cancer.
Genetics
Multiple hamartoma syndrome is primarily caused by mutations in the PTEN gene, which is a tumor suppressor gene. The PTEN gene provides instructions for making an enzyme that is involved in regulating cell division and preventing cells from growing and dividing too rapidly or in an uncontrolled way. Mutations in this gene can lead to the development of hamartomas and increase the risk of cancer.
Clinical Features
Individuals with multiple hamartoma syndrome may exhibit a variety of symptoms and signs, including:
- Multiple hamartomas in various tissues and organs
- Macrocephaly (an abnormally large head)
- Skin lesions such as trichilemmomas, papillomatous papules, and acral keratoses
- Oral mucosal lesions
- Gastrointestinal polyps
- Benign and malignant tumors of the breast, thyroid, and endometrium
Diagnosis
The diagnosis of multiple hamartoma syndrome is based on clinical criteria and genetic testing. The presence of multiple hamartomas, along with a family history of the syndrome or related cancers, may prompt genetic testing for mutations in the PTEN gene.
Management
Management of multiple hamartoma syndrome involves regular monitoring and screening for the development of cancers. This may include:
- Regular breast exams and imaging (such as mammograms or MRIs)
- Thyroid function tests and imaging
- Endometrial biopsies and imaging
- Dermatological evaluations for skin lesions
Related Conditions
Multiple hamartoma syndrome is part of a group of disorders known as PTEN hamartoma tumor syndromes (PHTS), which also includes Bannayan-Riley-Ruvalcaba syndrome and Proteus syndrome.
See Also
- Hamartoma
- PTEN
- Breast cancer
- Thyroid cancer
- Endometrial cancer
- PTEN hamartoma tumor syndromes
- Bannayan-Riley-Ruvalcaba syndrome
- Proteus syndrome
References
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
